Health care stocks were higher Friday afternoon, with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, AbbVie (ABBV) reported better-than-expected Q4 results amid robust sales of Skyrizi and Rinvoq, prompting the drugmaker to lift its long-term combined revenue outlook for the two immunology drugs. Its shares popped 5.4%.
Walgreens Boots Alliance (WBA) shares fell 7.8%. The company said Thursday its board has suspended quarterly dividend payments while management refines its capital allocation policy to be consistent with a long-term turnaround strategy.
AstraZeneca (AZN) has cancelled a plan to invest 450 million pounds ($558.3 million) in a UK vaccine plant in Liverpool. Its shares were down 0.4%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.